Silvant Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-15,191
| Closed | -$159K | – | 316 |
|
|
2022
Q3 | $159K | Hold |
15,191
| – | – | 0.01% | 211 |
|
|
2022
Q2 | $163K | Hold |
15,191
| – | – | 0.04% | 164 |
|
|
2022
Q1 | $144K | Hold |
15,191
| – | – | 0.03% | 197 |
|
|
2021
Q4 | $175K | Sell |
15,191
-977
| -6% | -$11.3K | 0.03% | 189 |
|
|
2021
Q3 | $154K | Hold |
16,168
| – | – | 0.03% | 201 |
|
|
2021
Q2 | $156K | Hold |
16,168
| – | – | 0.02% | 204 |
|
|
2021
Q1 | $160K | Hold |
16,168
| – | – | 0.03% | 201 |
|
|
2020
Q4 | $373K | Hold |
16,168
| – | – | 0.06% | 148 |
|
|
2020
Q3 | $228K | Buy |
16,168
+5,442
| +51% | +$76.7K | 0.04% | 165 |
|
|
2020
Q2 | $162K | Buy |
+10,726
| New | +$162K | 0.03% | 185 |
|